PABIR1 and lung cancer: It has been recently reported that inhibition of CHK1 reduces phosphorylation of FAM122A presumably on S37, increases binding to B55α and reduces binding of 14-3-3 proteins, which results in FAM122A upregulation in the nuclear fraction of A549 lung cancer cells23.